US · Healthcare · Medical Devices
EPS came in at -0.30 against a street estimate of -0.21 — a miss of 42.9%.
Analysts rate Anteris Technologies Global Corp. Common Stock a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $15.33.
| Fund | Stake |
|---|---|
| L1 Capital Pty Ltd | 7.99% |
| Sio Capital Management, LLC | 5.69% |
| Nantahala Capital Management, LLC | 5.68% |
| BlackRock Inc | 5.02% |
| ADAR1 Capital Management LLC | 3.89% |
| Perceptive Advisors LLC | 3.51% |
| Bvf Inc | 3.08% |
| RA Capital Management, LLC | 3.08% |
| Document | Date |
|---|---|
| Board / officer change · Q3 2026 ANTERIS TECHNOLOGIES GLOBAL CORP. - FORM 8-K SUMMARY HEADLINE NUMBERS • Company appointed new Chief Financial Officer effective September 11, 2026 • | 2026-09-08 |
| Results announced · Q3 2026 ANTERIS TECHNOLOGIES GLOBAL CORP – Q2 2026 RESULTS SUMMARY HEADLINE NUMBERS • Revenue (6 months to June 30, 2026): US$1,503,000 vs US$1,174,000 prio | 2026-08-12 |
| Quarterly report · Q2 2026 ANTERIS TECHNOLOGIES GLOBAL CORP. – Q2 2026 10-Q SUMMARY HEADLINE NUMBERS • Cash Position: $257.4 million in cash, cash equivalents and restricted c | 2026-08-11 |
| Reg FD disclosure · Q3 2026 ANTERIS TECHNOLOGIES GLOBAL CORP. - FORM 8-K SUMMARY HEADLINE NUMBERS • Report Date: August 3, 2026 • Company: Anteris Technologies Global Corp. • T | 2026-08-03 |
| Reg FD disclosure · Q3 2026 ANTERIS TECHNOLOGIES GLOBAL CORP. - FORM 8-K SUMMARY HEADLINE NUMBERS • Company: Anteris Technologies Global Corp. (Nasdaq: AVR, ASX: AVR) • Ticker/ | 2026-07-31 |
| Quarterly report · Q1 2026 ANTERIS TECHNOLOGIES GLOBAL CORP. – FORM 10-Q SUMMARY Quarter Ended March 31, 2026 --- HEADLINE NUMBERS • Cash position: $283.2 million as of March | 2026-05-12 |
| Annual report FY2025 ANTERIS TECHNOLOGIES GLOBAL CORP. – 10-K SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Company: Anteris Technologies Global Corp. (Nasdaq: AVR), D | 2026-02-26 |
| Quarterly report · Q3 2025 ANTERIS TECHNOLOGIES GLOBAL CORP. – Q3 2025 10-Q SUMMARY HEADLINE NUMBERS • Net sales (9 months 2025): $1,603 thousand vs. $2,167 thousand (2024) — | 2025-11-12 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Anteris Technologies Global Corp. Common Stock — free to start.
Google PlayApp StoreData updated 2026-09-18.